One Ascent Wealth Management LLC Collegium Pharmaceutical, Inc Transaction History

One Ascent Wealth Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$15.46 - $20.1 $52,965 - $68,862	-3,426 Reduced 23.43%	11,194 $179,000
Q2 2022 Aug 08, 2022	SELL	$14.22 - $20.88 $796 - $1,169	-56 Reduced 0.38%	14,620 $259,000
Q1 2022 May 12, 2022	BUY	$17.2 - $22.5 $9,374 - $12,262	545 Added 3.86%	14,676 $299,000
Q4 2021 Feb 08, 2022	BUY	$17.5 - $21.35 $12,250 - $14,945	700 Added 5.21%	14,131 $264,000
Q3 2021 Nov 12, 2021	SELL	$17.75 - $25.39 $92,850 - $132,815	-5,231 Reduced 28.03%	13,431 $265,000
Q1 2021 Apr 27, 2021	SELL	$19.25 - $26.1 $50,454 - $68,408	-2,621 Reduced 12.31%	18,662 $442,000
Q4 2020 Feb 08, 2021	BUY	$17.83 - $22.29 $379,475 - $474,398	21,283 New	21,283 $426,000

249

36.2M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.11B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of One Ascent Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on One Ascent Wealth Management LLC with notifications on news.